Respiratory Microbiome Disruption and Risk for Ventilator-Associated Lower Respiratory Tract Infection

James J Harrigan1, Hatem O Abdallah1, Erik L Clarke2

  • 1Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Abstract

Insights

Persistent disruption of the respiratory microbiome, indicated by low Shannon diversity over consecutive days, predicts ventilator-associated lower respiratory tract infection (VA-LRTI) risk in prolonged mechanical ventilation. This finding may help target infection prevention strategies.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Microbiome Research

Background:

  • Ventilator-associated lower respiratory tract infection (VA-LRTI) is a significant complication in critically ill patients, increasing morbidity and mortality.
  • Microbiome disruption indices (MDIs) predict VA-LRTI risk in acute illness, but their role in prolonged mechanical ventilation is unclear.

Purpose of the Study:

  • To investigate changes in respiratory microbiome disruption indices (MDIs) during prolonged mechanical ventilation.
  • To determine if these MDIs remain associated with VA-LRTI risk over time.

Main Methods:

  • A cohort of 83 subjects on prolonged mechanical ventilation was studied.
  • Longitudinal lower respiratory tract samples were collected and analyzed using 16S rRNA sequencing and qPCR.
  • Microbiome disruption indices (MDIs) were calculated, including Shannon diversity and bacterial abundance.

Main Results:

  • Cross-sectional MDIs showed weak associations with VA-LRTI risk.
  • Persistent lower respiratory microbiome disruption, defined by consecutive days with low Shannon diversity (<2.0), robustly predicted VA-LRTI risk (OR 1.36 per day).
  • The association was consistent across different VA-LRTI definitions.

Conclusions:

  • Cross-sectional MDIs have limited utility for predicting VA-LRTI risk in prolonged mechanical ventilation.
  • Persistent lower respiratory tract microbiome disruption, particularly low Shannon diversity over consecutive days, identifies patients at high risk for VA-LRTI.
  • This understanding can inform targeted infection prevention interventions.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
427
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
461
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.0K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
415
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
244
Mechanical Ventilation II: Invasive Ventilation01:23

Mechanical Ventilation II: Invasive Ventilation

Ventilators are essential medical equipment used to aid patients with respiratory difficulties. Their primary function is to assist or replace spontaneous breathing by providing mechanical ventilation. There are two general classes of mechanical ventilators: negative-pressure and positive-pressure ventilators.
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
390